Presentation is loading. Please wait.

Presentation is loading. Please wait.

Date of download: 6/25/2016 From: Cost-Effectiveness of the Children's Oncology Group Long-Term Follow-up Screening Guidelines for Childhood Cancer Survivors.

Published byRodney Burke Modified over 8 years ago

Similar presentations

Presentation on theme: "Date of download: 6/25/2016 From: Cost-Effectiveness of the Children's Oncology Group Long-Term Follow-up Screening Guidelines for Childhood Cancer Survivors."— Presentation transcript:

1 Date of download: 6/25/2016 From: Cost-Effectiveness of the Children's Oncology Group Long-Term Follow-up Screening Guidelines for Childhood Cancer Survivors at Risk for Treatment-Related Heart Failure Ann Intern Med. 2014;160(10):672-683. doi:10.7326/M13-2498 Four–health state transition diagram. ALVD = asymptomatic left ventricular dysfunction; HF = heart failure. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

2 Date of download: 6/25/2016 From: Cost-Effectiveness of the Children's Oncology Group Long-Term Follow-up Screening Guidelines for Childhood Cancer Survivors at Risk for Treatment-Related Heart Failure Ann Intern Med. 2014;160(10):672-683. doi:10.7326/M13-2498 Annual incidence of HF, by years since cancer diagnosis, for age at cancer diagnosis younger than 5 y. HF = heart failure. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

3 Date of download: 6/25/2016 From: Cost-Effectiveness of the Children's Oncology Group Long-Term Follow-up Screening Guidelines for Childhood Cancer Survivors at Risk for Treatment-Related Heart Failure Ann Intern Med. 2014;160(10):672-683. doi:10.7326/M13-2498 Annual incidence of HF, by years since cancer diagnosis, for age at cancer diagnosis 5 y or older. HF = heart failure. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

4 Date of download: 6/25/2016 From: Cost-Effectiveness of the Children's Oncology Group Long-Term Follow-up Screening Guidelines for Childhood Cancer Survivors at Risk for Treatment-Related Heart Failure Ann Intern Med. 2014;160(10):672-683. doi:10.7326/M13-2498 Annual non-HF mortality, by attained age. HF = heart failure; RR = relative risk (compared with the U.S. population). Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

5 Date of download: 6/25/2016 From: Cost-Effectiveness of the Children's Oncology Group Long-Term Follow-up Screening Guidelines for Childhood Cancer Survivors at Risk for Treatment-Related Heart Failure Ann Intern Med. 2014;160(10):672-683. doi:10.7326/M13-2498 Tornado diagrams of the 1-way sensitivity analyses for ICER and the percentage reduction in the cumulative incidence of HF at 30 y after cancer diagnosis, by varying key variables. HF = heart failure; ICER = incremental cost-effectiveness ratio; QALY = quality-adjusted life-year. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

6 Date of download: 6/25/2016 From: Cost-Effectiveness of the Children's Oncology Group Long-Term Follow-up Screening Guidelines for Childhood Cancer Survivors at Risk for Treatment-Related Heart Failure Ann Intern Med. 2014;160(10):672-683. doi:10.7326/M13-2498 Two-way sensitivity analyses for ICERs, by varying the efficacy of ALVD treatment and the sensitivity and specificity of echocardiography for detecting ALVD. ALVD = asymptomatic left ventricular dysfunction; ICER = incremental cost-effectiveness ratio; QALY = quality-adjusted life-year. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

7 Date of download: 6/25/2016 From: Cost-Effectiveness of the Children's Oncology Group Long-Term Follow-up Screening Guidelines for Childhood Cancer Survivors at Risk for Treatment-Related Heart Failure Ann Intern Med. 2014;160(10):672-683. doi:10.7326/M13-2498 Copyright © American College of Physicians. All rights reserved.American College of Physicians

Download ppt "Date of download: 6/25/2016 From: Cost-Effectiveness of the Children's Oncology Group Long-Term Follow-up Screening Guidelines for Childhood Cancer Survivors."

Similar presentations

Date of download: 5/28/2016 From: Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S.

Date of download: 5/28/2016 From: Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S.
Date of download: 5/29/2016 From: The Effect of a Lower Target Blood Pressure on the Progression of Kidney Disease: Long-Term Follow- up of the Modification.

Date of download: 5/29/2016 From: The Effect of a Lower Target Blood Pressure on the Progression of Kidney Disease: Long-Term Follow- up of the Modification.
Date of download: 5/31/2016 From: Cost-Effectiveness of HIV Screening in Patients Older than 55 Years of Age Ann Intern Med. 2008;148(12):889-903. doi:10.7326/0003-4819-148-12-200806170-00002.

Date of download: 5/31/2016 From: Cost-Effectiveness of HIV Screening in Patients Older than 55 Years of Age Ann Intern Med. 2008;148(12): doi: /
Date of download: 5/31/2016 From: Medications for Risk Reduction of Primary Breast Cancer in Women: U.S. Preventive Services Task Force Recommendation.

Date of download: 5/31/2016 From: Medications for Risk Reduction of Primary Breast Cancer in Women: U.S. Preventive Services Task Force Recommendation.
Date of download: 5/31/2016 From: Urinary Biomarkers for Diagnosis of Bladder Cancer: A Systematic Review and Meta-analysis Ann Intern Med. 2015;163(12):922-931.

Date of download: 5/31/2016 From: Urinary Biomarkers for Diagnosis of Bladder Cancer: A Systematic Review and Meta-analysis Ann Intern Med. 2015;163(12):
Date of download: 5/31/2016 From: Benefits, Harms, and Cost-Effectiveness of Supplemental Ultrasonography Screening for Women With Dense Breasts Ann Intern.

Date of download: 5/31/2016 From: Benefits, Harms, and Cost-Effectiveness of Supplemental Ultrasonography Screening for Women With Dense Breasts Ann Intern.
Date of download: 6/1/2016 From: Cost-Effectiveness of Novel Regimens for the Treatment of Hepatitis C Virus Ann Intern Med. 2015;162(6):407-419. doi:10.7326/M14-1152.

Date of download: 6/1/2016 From: Cost-Effectiveness of Novel Regimens for the Treatment of Hepatitis C Virus Ann Intern Med. 2015;162(6): doi: /M
Date of download: 6/1/2016 From: Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms.

Date of download: 6/1/2016 From: Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms.
Date of download: 6/1/2016 From: Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons Ann Intern Med. 2016;164(2):84-92. doi:10.7326/M15-0617.

Date of download: 6/1/2016 From: Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons Ann Intern Med. 2016;164(2): doi: /M
Date of download: 6/2/2016 From: New Protease Inhibitors for the Treatment of Chronic Hepatitis C: A Cost-Effectiveness Analysis Ann Intern Med. 2012;156(4):279-290.

Date of download: 6/2/2016 From: New Protease Inhibitors for the Treatment of Chronic Hepatitis C: A Cost-Effectiveness Analysis Ann Intern Med. 2012;156(4):
Date of download: 6/2/2016 From: Screening for Vitamin D Deficiency: A Systematic Review for the U.S. Preventive Services Task Force Ann Intern Med. 2015;162(2):109-122.

Date of download: 6/2/2016 From: Screening for Vitamin D Deficiency: A Systematic Review for the U.S. Preventive Services Task Force Ann Intern Med. 2015;162(2):
Date of download: 6/3/2016 From: Mortality Rates in Elderly Patients Who Take Different Angiotensin-Converting Enzyme Inhibitors after Acute Myocardial.

Date of download: 6/3/2016 From: Mortality Rates in Elderly Patients Who Take Different Angiotensin-Converting Enzyme Inhibitors after Acute Myocardial.
Date of download: 6/3/2016 From: Chest Pain Relief by Nitroglycerin Does Not Predict Active Coronary Artery Disease Ann Intern Med. 2003;139(12):979-986.

Date of download: 6/3/2016 From: Chest Pain Relief by Nitroglycerin Does Not Predict Active Coronary Artery Disease Ann Intern Med. 2003;139(12):
Date of download: 6/3/2016 From: Sex, Age, and Birth Cohort Effects in Colorectal Neoplasms: A Cohort Analysis Ann Intern Med. 2010;152(11):697-703. doi:10.7326/0003-4819-152-11-201006010-00002.

Date of download: 6/3/2016 From: Sex, Age, and Birth Cohort Effects in Colorectal Neoplasms: A Cohort Analysis Ann Intern Med. 2010;152(11): doi: /
Date of download: 6/3/2016 From: Surgery Versus Nonsurgical Treatment of Lumbar Spinal Stenosis: A Randomized Trial Ann Intern Med. 2015;162(7):465-473.

Date of download: 6/3/2016 From: Surgery Versus Nonsurgical Treatment of Lumbar Spinal Stenosis: A Randomized Trial Ann Intern Med. 2015;162(7):
Date of download: 6/3/2016 From: Increased Incidence of Aortic Aneurysm and Dissection in Giant Cell (Temporal) Arteritis: A Population- Based Study Ann.

Date of download: 6/3/2016 From: Increased Incidence of Aortic Aneurysm and Dissection in Giant Cell (Temporal) Arteritis: A Population- Based Study Ann.
Date of download: 6/3/2016 From: Cost-Effectiveness of Treatment of Diabetic Macular Edema Ann Intern Med. 2014;160(1):18-29. doi:10.7326/M13-0768 Markov.

Date of download: 6/3/2016 From: Cost-Effectiveness of Treatment of Diabetic Macular Edema Ann Intern Med. 2014;160(1): doi: /M Markov.
Date of download: 6/9/2016 From: Cost-Effectiveness of Preparticipation Screening for Prevention of Sudden Cardiac Death in Young Athletes Ann Intern Med.

Date of download: 6/9/2016 From: Cost-Effectiveness of Preparticipation Screening for Prevention of Sudden Cardiac Death in Young Athletes Ann Intern Med.
Date of download: 6/18/2016 From: Treatment of Anemia in Patients With Heart Disease: A Systematic Review Ann Intern Med. 2013;159(11):746-757. doi:10.7326/0003-4819-159-11-201312030-00007.

Date of download: 6/18/2016 From: Treatment of Anemia in Patients With Heart Disease: A Systematic Review Ann Intern Med. 2013;159(11): doi: /
Date of download: 6/21/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Cost-effectiveness Analysis of Herpes Simplex Virus.

Date of download: 6/21/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Cost-effectiveness Analysis of Herpes Simplex Virus.

Similar presentations

Ads by Google